A phenotypic assay to identify chikungunya virus inhibitors targeting the nonstructural protein nsP2

Journal of Biomolecular Screening

Volumn 18, Issue 2, 2013, Pages 172-179

  Lucas Hourani, Marianne ^a,b   Lupan, Alexandru ^a,b,d   Desprès, Philippe ^a   Thoret, Sylviane ^c   Pamlard, Olivier ^c   Dubois, Joëlle ^c   Guillou, Catherine ^c   Tangy, Frédéric ^a,b   Vidalain, Pierre Olivier ^a,b   Munier Lehmann, Hélène ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

^d BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

antiviral; Chikungunya virus; nsP2; phenotypic assay

Indexed keywords

PROTEIN NSP2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE; CHIKUNGUNYA VIRUS; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; SMALL MOLECULE LIBRARIES; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

CHIKUNGUNYA VIRUS;

EID: 84872593101     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112460091     Document Type: Article

References (38)

1. de Wet J. R., Wood K. V., DeLuca M., Helinski D. R., Subramani S.. Firefly Luciferase Gene: Structure and Expression in Mammalian Cells. Mol. Cell. Biol. 1987 ; 7: 725-737
2. Fan F., Wood K. V.. Bioluminescent Assays for High-Throughput Screening. Assay Drug Dev. Technol. 2007 ; 5: 127-136
3. Remy I., Michnick S. W.. A Highly Sensitive Protein-Protein Interaction Assay Based on Gaussia Luciferase. Nat. Methods. 2006 ; 3: 977-979
4. Summers B. C., Leib D. A.. Herpes Simplex Virus Type 1 Origins of DNA Replication Play No Role in the Regulation of Flanking Promoters. J. Virol. 2002 ; 76: 7020-7029
5. Cook S. H., Griffin D. E.. Luciferase Imaging of a Neurotropic Viral Infection in Intact Animals. J. Virol. 2003 ; 77: 5333-5338
6. Samsa M. M., Mondotte J. A., Iglesias N. G., Assunção- Miranda I., Barbosa-Lima G., Da Poian A. T., Bozza P. T., Gamarnik A. V.. Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation. PLoS Pathog. 2009 ; 5: e1000632
7. Liang H., Tan Y., Dun C., Guo X.. A Recombinant Rabies Virus Expressing Luciferase. Acta Virol. 2010 ; 54: 269-274
8. Komarova A. V., Combredet C., Meyniel-Schicklin L., Chapelle M., Caignard G., Camadro J. M., Lotteau V., Vidalain P. O., Tangy F.. Proteomic Analysis of Virus-Host Interactions in an Infectious Context Using Recombinant Viruses. Mol. Cell Proteomics. 2011 ; 10: M110 007443
9. Schnell M. J., Conzelmann K. K.. Polymerase Activity of In Vitro Mutated Rabies Virus L Protein. Virology. 1995 ; 214: 522-530
10. Pohjala L., Utt A., Varjak M., Lulla A., Merits A., Ahola T., Tammela P.. Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays. PLoS One. 2011 ; 6: e28923
11. Betzi S., Restouin A., Opi S., Arold S. T., Parrot I., Guerlesquin F., Morelli X., Collette Y.. Protein Protein Interaction Inhibition (2P2I) Combining High Throughput and Virtual Screening: Application to the HIV-1 Nef Protein. Proc. Natl. Acad. Sci. U. S. A. 2007 ; 104: 19256-19261
12. Burt F. J., Rolph M. S., Rulli N. E., Mahalingam S., Heise M. T.. Chikungunya: A Re-emerging Virus. Lancet. 2012 ; 379: 662-671
13. Rezza G., Nicoletti L., Angelini R., Romi R., Finarelli A. C., Panning M., Cordioli P., Fortuna C., Boros S., Magurano F., et al. Infection with Chikungunya Virus in Italy: An Outbreak in a Temperate Region. Lancet. 2007 ; 370: 1840-1846
14. Grandadam M., Caro V., Plumet S., Thiberge J. M., Souarès Y., Failloux A. B., Tolou H. J., Budelot M., Cosserat D., Leparc-Goffart I., et al. Chikungunya Virus, Southeastern France. Emerg. Infect. Dis. 2011 ; 17: 910-913
15. de Lamballerie X., Ninove L., Charrel R. N.. Antiviral Treatment of Chikungunya Virus Infection. Infect. Disord. Drug Targets. 2009 ; 9: 101-104
16. Akahata W., Yang Z. Y., Andersen H., Sun S., Holdaway H. A., Kong W. P., Lewis M. G., Higgs S., Rossmann M. G., Rao S., et al. A Virus-Like Particle Vaccine for Epidemic Chikungunya Virus Protects Nonhuman Primates against Infection. Nat. Med. 2010 ; 16: 334-338
17. Couderc T., Khandoudi N., Grandadam M., Visse C., Gangneux N., Bagot S., Prost J. F., Lecuit M.. Prophylaxis and Therapy for Chikungunya Virus Infection. J. Infect. Dis. 2009 ; 200: 516-523
18. Gardner J., Anraku I., Le T. T., Larcher T., Major L., Roques P., Schroder W. A., Higgs S., Suhrbier A.. Chikungunya Virus Arthritis in Adult Wild-Type Mice. J. Virol. 2010 ; 84: 8021-8032
19. Ravichandran R., Manian M.. Ribavirin Therapy for Chikungunya Arthritis. J. Infect. Dev. Ctries. 2008 ; 2: 140-142
20. Briolant S., Garin D., Scaramozzino N., Jouan A., Crance J. M.. In Vitro Inhibition of Chikungunya and Semliki Forest Viruses Replication by Antiviral Compounds: Synergistic Effect of Interferon-Alpha and Ribavirin Combination. Antiviral Res. 2004 ; 61: 111-117
21. Ozden S., Lucas-Hourani M., Ceccaldi P. E., Basak A., Valentine M., Benjannet S., Hamelin J., Jacob Y., Mamchaoui K., Mouly V., et al. Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors: Impairment of the Maturation of the E2 Surface Glycoprotein. J. Biol. Chem. 2008 ; 283: 21899-21908
22. Brighton S. W.. Chloroquine Phosphate Treatment of Chronic Chikungunya Arthritis: An Open Pilot Study. S. Afr. Med. J. 1984 ; 66: 217-218
23. De Lamballerie X., Boisson V., Reynier J. C., Enault S., Charrel R. N., Flahault A., Roques P., Le Grand R.. On Chikungunya Acute Infection and Chloroquine Treatment. Vector Borne Zoonotic Dis. 2008 ; 8: 837-839
24. Khan M., Dhanwani R., Patro I. K., Rao P. V., Parida M. M.. Cellular IMPDH Enzyme Activity Is a Potential Target for the Inhibition of Chikungunya Virus Replication and Virus Induced Apoptosis in Cultured Mammalian Cells. Antiviral Res. 2011 ; 89: 1-8
25. Griffin D. E. Fields Virology;. 2007 ; 5th ed., pp. 1023-1067. Knipe D. M. Howley P. M., ed. Philadelphia, PA: Wolters Kluwer, Lippincott Williams & Wilkins ; 2007: 1023-1067.
26. Kuhn R. J. Fields Virology;. 2007 ; 5th ed., pp. 1001-1022. Knipe D. M. Howley P. M., ed. Philadelphia, PA: Wolters Kluwer, Lippincott Williams & Wilkins ; 2007: 1001-1022.
27. Jose J., Snyder J. E., Kuhn R. J.. A Structural and Functional Perspective of Alphavirus Replication and Assembly. Future Microbiol. 2009 ; 4: 837-856
28. Fros J. J., Liu W. J., Prow N. A., Geertsema C., Ligtenberg M., Vanlandingham D. L., Schnettler E., Vlak J. M., Suhrbier A., Khromykh A. A., et al. Chikungunya Virus Nonstructural Protein 2 Inhibits Type I/II Interferon-Stimulated JAK-STAT Signaling. J. Virol. 2010 ; 84: 10877-10887
29. White L. K., Sali T., Alvarado D., Gatti E., Pierre P., Streblow D., Defilippis V. R.. Chikungunya Virus Induces IPS-1-Dependent Innate Immune Activation and Protein Kinase R-Independent Translational Shutoff. J. Virol. 2011 ; 85: 606-620
30. Bouraï M., Lucas-Hourani M., Gad H. H., Drosten C., Jacob Y., Tafforeau L., Cassonnet P., Jones L. M., Judith D., Couderc T., et al. Mapping of Chikungunya Virus Interactions with Host Proteins Identified nsP2 as a Highly Connected Viral Component. J. Virol. 2012 ; 86: 3121-3134
31. Akhrymuk I., Kulemzin S. V., Frolova E. I.. Evasion of Innate Immune Response: The Old World Alphavirus nsP2 Protein Induces Rapid Degradation of Rpb1, a Catalytic Subunit of RNA Polymerase II. J. Virol. 2012 ; 86: 7180-7191
32. Kummerer B. M., Grywna K., Glasker S., Wieseler J., Drosten C.. Construction of an Infectious Chikungunya Virus cDNA Clone and Stable Insertion of mCherry Reporter Genes at Two Different Sites. J. Gen. Virol. 2012 ; 93 (Pt 9). 1991-1995
33. Zhang J. H., Chung T. D., Oldenburg K. R.. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999 ; 4: 67-73
34. Frolova E. I., Fayzulin R. Z., Cook S. H., Griffin D. E., Rice C. M., Frolov I.. Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection. J. Virol. 2002 ; 76: 11254-11264
35. Breakwell L., Dosenovic P., Karlsson Hedestam G. B., D'Amato M., Liljeström P., Fazakerley J., McInerney G. M.. Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon Response. J. Virol. 2007 ; 81: 8677-8684
36. Steuber H., Hilgenfeld R.. Recent Advances in Targeting Viral Proteases for the Discovery of Novel Antivirals. Curr. Top. Med. Chem. 2010 ; 10: 323-345
37. De Luca L., Ferro S., Morreale F., De Grazia S., Chimirri A.. Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75. ChemMedChem. 2011 ; 6: 1184-1191
38. Henrik GadH.. The E2-E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry. Virology. 2012, http://dx.doi.org/10.1016/j.virol.2012.07.019.